TABLE 1.
Gender, n (%) | |
Men | 99 (23%) |
Women | 339 (77%) |
Age (yr) | |
Median [range]; mean ± SD | 51 [15-83]; 51.13 ± 12.28 |
Karnofsky Performance Index before SRS (score) | |
Median [range]; mean ± SD | 90 [50-100]; 85.31 ± 13.97 |
Data not reported | 244 (56%) |
Pre-SRS visual deficit, n (%) | |
Yes | 257 (59%) |
No | 181 (41%) |
Other presenting symptoms, na | |
Headache | 85 |
Diplopia | 43 |
Ptosis | 41 |
Incidental | 35 |
Seizure | 18 |
Other | 62 |
Duration of symptoms (mo) | |
Median [range]; mean ± SD | 10 [0-240]; 19.60 ± 30.23 |
Unknown or data not available | 71 (16%) |
Pre-SRS endocrinopathy, n (%) | |
None | 412 (94%) |
Hypothyroidism | 15 (3%) |
Estrogen/testosterone deficiency | 3 (1%) |
Diabetes insipidus | 1 (0%) |
Not reported | 7 (2%) |
Nearest distance to the optic apparatus (mm) | |
Median [range]; mean ± SD | 0 [0-2.3]; 0.36 ± 0.67 |
In direct contact with optic pathway | 328 (75%) |
Meningioma principal location, n (%) | |
Clinoid | 191 (44%) |
Tuberculum sella | 136 (31%) |
Sphenoid wing | 31 (7%) |
Planum sphenoidale | 17 (4%) |
Clival/petroclival | 15 (3%) |
Parasellar | 10 (2%) |
Suprasellar | 8 (2%) |
Intraorbital | 4 (1%) |
Intrasellar | 2 (1%) |
Optic sheath | 1 (0%) |
Temporal pole | 1 (0%) |
Frontobasal | 1 (0%) |
Optic nerve sheath | 1 (0%) |
Not specified/other | 8 (2%) |
Other meningiomas, n (%) | 77 (8%) |
Index meningioma surgery before SRS, n (%) | 153 (35%) |
Number of prior resections, n (%) | |
1 | 121 (79%) |
2 | 28 (18%) |
3 | 3 (2%) |
4 | 1 (1%) |
Type of prior resection, n (%) | |
Gross total resection | 21 (14%) |
Subtotal resection | 120 (79%) |
Biopsy | 9 (6%) |
Data not available | 2 (1%) |
Interval between surgery and SRS (mo) | |
Median [range]; mean ± SD | 9 [1-246]; 28.32 ± 44.57 |
Meningioma WHO grade, n (%) | |
I | 124 (28%) |
II | 2 (1%) |
No pre-SRS surgery or data not available | 312 (71%) |
Histological type of index meningioma, n (%) | |
Meningothelial | 30 (7%) |
Transitional | 28 (6%) |
Psammomatous | 10 (2%) |
Fibroblastic | 5 (1%) |
Mixed transitional and fibroblastic | 5 (1%) |
Angiomatous | 1 (0.2%) |
Microcystic | 1 (0.2%) |
Secretory | 1 (0.2%) |
Atypical | 1 (0.2%) |
No pre-SRS surgery or data not available | 356 (81%) |
Pre-SRS fractionated radiation therapy, n (%) | 10 (2%) |
Pre-SRS radiation therapy dose (Gy) | |
Median [range]; mean ± SD | 45 [13-60]; 40.42 ± 18.15 |
Data not available | 4 (40%) |
Pre-SRS radiation therapy number of fractions | |
Median [range]; mean ± SD | 17 [1-30]; 15.67 ± 12.21 |
Data not available | 4 (40%) |
SD, standard deviation.
aTotal number does not add up to 438 because some patients had more than 1 presenting symptom.